Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer [NA]
A clinical trial evaluating robot-assisted radical prostatectomy with or without vesicopexy for prostate cancer is currently suspended.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients [NA]
Clinical trial investigating the effects of physical activity versus dietary energy restriction on tumour and muscle protein synthesis in me…
-
EMA approval · 2026-01-16EMA Authorised: Abiraterone Krka (abiraterone acetate) — Krka, d.d., Novo mesto
EMA authorised Abiraterone Krka (abiraterone acetate) for prostatic neoplasms (prostate cancer); decision date 18 December 2025.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) [Phase 2]
Phase 2 FORCE trial evaluating focal radiation for oligometastatic castration-resistant prostate cancer has completed, with results posted.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC) [Phase 1]
Phase 1 clinical trial evaluating autologous T cells engineered to target PSMA for men with metastatic castration-resistant prostate cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Vitamin D for Prostate Endocrine Therapy [Phase 3]
A Phase 3 clinical trial evaluating vitamin D as an adjunct to prostate endocrine therapy is currently recruiting across stages I–IVA prosta…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy [Phase 1, Phase 2]
Presurgical Phase 1/2 trial evaluating REGN5678, an Anti-PSMA x CD28 bispecific, in high-risk localized prostate cancer patients planned for…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer [NA]
This clinical trial update notes that an adaptive stereotactic radiotherapy approach for localized prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer [NA]
Clinical Trial Update describes a study evaluating educational interventions to improve completion of genetic testing in Black patients with…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Sample Collection for Ongoing Research and Product Evaluation Study
Natera reports an ongoing study update focused on sample collection for ongoing research and product evaluation; the trial is currently recr…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study of DM002 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial for DM002 in patients with advanced solid tumors is recruiting, including ovarian cancer, prostate cancer, endometria…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer [Phase 3]
A Phase 3 randomized trial comparing stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) for Stag…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy [Phase 1]
Phase 1 feasibility study evaluating maintenance therapy for biochemically progressive castration-sensitive prostate cancer in patients on i…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
University of Washington is conducting a trial to collect blood and tissue samples from patients with locally recurrent or metastatic prosta…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning [NA]
A clinical trial update for UFPTI 2403-PR12 studying real-time volumetric ionizing radiation acoustic imaging to monitor in-vivo proton ther…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Prostate Active Surveillance Study
A University of Washington-sponsored prostate cancer active surveillance clinical trial is currently recruiting participants.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Phase I Trial of A-CAR032 in Participants With mCRPC [Phase 1]
The document details a Phase I clinical trial of A-CAR032 for metastatic castration-resistant prostate cancer, with the study currently recr…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Evaluation of Neuromuscular ElectroStimulation in Addition to a Physical Activity Program [NA]
A clinical trial evaluating neuromuscular electrostimulation in addition to a physical activity program for prostate cancer patients; the st…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Streamlined Geriatric and Oncological Evaluation Based On IC Technology [NA]
This clinical trial update notes that recruitment is ongoing for a study evaluating a streamlined geriatric and oncological evaluation based…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Efficacy of Ra-223 in PSMA PET Optimally Selected Patients [Phase 2]
Phase 2 trial update evaluating the efficacy of Radium-223 dichloride in PSMA PET–selected patients with castration-resistant, metastatic pr…
-
EMA approval · 2026-01-14EMA Authorised: Abiraterone Accord (abiraterone acetate) — Accord Healthcare S.L.U.
The European Medicines Agency authorised Abiraterone Accord (abiraterone acetate) for use in prostate cancer, with Accord Healthcare S.L.U. …
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial [Phase 3]
The INNOVATE Phase 3 trial is evaluating adding apalutamide to standard hormone therapy and radiation after prostate cancer surgery and is c…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
This update describes a clinical study investigating how lifestyle behaviors influence health outcomes among African American prostate cance…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery [Phase 2, Phase 3]
Clinical trial update describing Phase 2/3 evaluation of antiandrogen therapy with radiation, with or without the chemotherapy drug docetaxe…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study [Phase 2]
A Phase 2 clinical trial (SPECTRA) is evaluating whether supraphysiological androgen can enhance treatment activity in metastatic castration…